Danger signalling during cancer cell death: origins, plasticity and regulation

per Garg, A D, Martin, S, Golab, J, Agostinis, P
Publicat 2014

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

per Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, M
Publicat a Blood Cancer J (2015)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy

per Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J
Publicat 2013

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

per Golab, J, Wilczynski, G, Zagozdzon, R, Stoklosa, T, Dabrowska, A, Rybczynska, J, Wasik, M, Machaj, E, Oldak, T, Kozar, K, Kaminski, R, Giermasz, A, Czajka, A, Lasek, W, Feleszko, W, Jakobisiak, M
Publicat 2000

Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity

per Nowis, D, Legat, M, Grzela, T, Niderla, J, Wilczek, E, Wilczyñski, GM, Głodkowska, E, Mrówka, P, Issat, T, Dulak, J, Józkowicz, A, Waś, H, Adamek, M, Wrzosek, A, Nazarewski, S, Makowski, M, Stokłosa, T, Jakóbisiak, M, Gołąb, J
Publicat 2006